Degron Therapeutics Funding: $22M Raised, Series A (2022)
Degron Therapeutics is based in San Diego. It has raised $22M in total funding. Latest round: Series A.
Degron Therapeutics funding overview
Degron Therapeutics is based in San Diego. Degron Therapeutics has raised $22M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in June 2022. The round record for Degron Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Med-Fine Capital, Dyee Capital, Baidu Venture, NeuX Capital, CO-WIN Ventures, Yuanbio Venture Capital. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Degron Therapeutics funding
How much has Degron Therapeutics raised?
Degron Therapeutics has raised $22M in total disclosed funding across the rounds on record.
Who has invested in Degron Therapeutics?
Med-Fine Capital, Dyee Capital, Baidu Venture, NeuX Capital, CO-WIN Ventures, Yuanbio Venture Capital are named among the investors backing Degron Therapeutics.
What was the latest Degron Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2022.
Where is Degron Therapeutics based?
Degron Therapeutics is based in San Diego.
When did Degron Therapeutics last raise?
The last disclosed Degron Therapeutics round closed in June 2022 at Series A.
Totals shown for Degron Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.
